These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 29285812

  • 1. Are government-approved products containing new psychoactive substances perceived to be safer and more socially acceptable than alcohol, tobacco and illegal drugs? Findings from a survey of police arrestees in New Zealand.
    Rychert M, Wilkins C, Parker K, Witten K.
    Drug Alcohol Rev; 2018 Mar; 37(3):406-413. PubMed ID: 29285812
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Issues with monitoring the safety of psychoactive products under a legal regulated market for new psychoactive substances ('legal highs') in New Zealand.
    Rychert M, Wilkins C, Witten K.
    Drug Alcohol Rev; 2017 Sep; 36(5):589-596. PubMed ID: 28229493
    [Abstract] [Full Text] [Related]

  • 4. A critical first assessment of the new pre-market approval regime for new psychoactive substances (NPS) in New Zealand.
    Wilkins C.
    Addiction; 2014 Oct; 109(10):1580-6. PubMed ID: 24529166
    [Abstract] [Full Text] [Related]

  • 5. An exploratory study of the health harms and utilisation of health services of frequent legal high users under the interim regulated legal high market in central Auckland.
    Wilkins C, Prasad J, Wong KC, Rychert M, Graydon-Guy T.
    N Z Med J; 2016 Mar 11; 129(1431):51-8. PubMed ID: 27005874
    [Abstract] [Full Text] [Related]

  • 6. Legal high industry business and lobbying strategies under a legal market for new psychoactive substances (NPS, 'legal highs') in New Zealand.
    Rychert M, Wilkins C.
    Int J Drug Policy; 2016 Nov 11; 37():90-97. PubMed ID: 27639994
    [Abstract] [Full Text] [Related]

  • 7. A critical analysis of the implementation of a legal regulated market for new psychoactive substances ("legal highs") in New Zealand.
    Rychert M, Wilkins C.
    Int J Drug Policy; 2018 May 11; 55():88-94. PubMed ID: 29524738
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. "They're legal so they're safe, right?" What did the legal status of BZP-party pills mean to young people in New Zealand?
    Sheridan J, Butler R.
    Int J Drug Policy; 2010 Jan 11; 21(1):77-81. PubMed ID: 19321329
    [Abstract] [Full Text] [Related]

  • 11. What products are considered psychoactive under New Zealand's legal market for new psychoactive substances (NPS, 'legal highs')? Implications for law enforcement and penalties.
    Rychert M, Wilkins C.
    Drug Test Anal; 2016 Aug 11; 8(8):768-78. PubMed ID: 26857892
    [Abstract] [Full Text] [Related]

  • 12. Driving under the influence among frequent ecstasy consumers in Australia: trends over time and the role of risk perceptions.
    Matthews AJ, Bruno R, Dietze P, Butler K, Burns L.
    Drug Alcohol Depend; 2014 Nov 01; 144():218-24. PubMed ID: 25282306
    [Abstract] [Full Text] [Related]

  • 13. Do novel psychoactive substances displace established club drugs, supplement them or act as drugs of initiation? The relationship between mephedrone, ecstasy and cocaine.
    Moore K, Dargan PI, Wood DM, Measham F.
    Eur Addict Res; 2013 Nov 01; 19(5):276-82. PubMed ID: 23615495
    [Abstract] [Full Text] [Related]

  • 14. Characteristics of the use of 3-MMC and other new psychoactive drugs in Slovenia, and the perceived problems experienced by users.
    Sande M.
    Int J Drug Policy; 2016 Jan 01; 27():65-73. PubMed ID: 25908121
    [Abstract] [Full Text] [Related]

  • 15. The rise of new psychoactive substance use in Australia.
    Burns L, Roxburgh A, Matthews A, Bruno R, Lenton S, Van Buskirk J.
    Drug Test Anal; 2014 Jan 01; 6(7-8):846-9. PubMed ID: 24599890
    [Abstract] [Full Text] [Related]

  • 16. Patterns and correlates of new psychoactive substance use in a sample of Australian high school students.
    Champion KE, Teesson M, Newton NC.
    Drug Alcohol Rev; 2016 May 01; 35(3):338-44. PubMed ID: 26194894
    [Abstract] [Full Text] [Related]

  • 17. Typology of new psychoactive substance use among the general Australian population.
    Sutherland R, Peacock A, Roxburgh A, Barratt MJ, Burns L, Bruno R.
    Drug Alcohol Depend; 2018 Jul 01; 188():126-134. PubMed ID: 29775956
    [Abstract] [Full Text] [Related]

  • 18. The diverse reasons for using Novel Psychoactive Substances - A qualitative study of the users' own perspectives.
    Soussan C, Andersson M, Kjellgren A.
    Int J Drug Policy; 2018 Feb 01; 52():71-78. PubMed ID: 29241144
    [Abstract] [Full Text] [Related]

  • 19. New psychoactive substances: issues about the new approach from New Zealand government.
    von Diemen L.
    Addiction; 2014 Oct 01; 109(10):1588-9. PubMed ID: 25163704
    [No Abstract] [Full Text] [Related]

  • 20. Harms associated with psychoactive substances: findings of the UK National Drug Survey.
    Morgan CJ, Muetzelfeldt L, Muetzelfeldt M, Nutt DJ, Curran HV.
    J Psychopharmacol; 2010 Feb 01; 24(2):147-53. PubMed ID: 19939875
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.